Axtria's pharma-native AgentOps framework and LangChain's leading agent development platform help life sciences enterprises deploy AI agents with confidence and…
MUMBAI, India, April 28, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health…
TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…
ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a…
Piramal Pharma Solutions is a global leader in antibody-drug conjugate (ADC) development and manufacturing, leveraging over 20 years of specialized…
A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial…
Honored for AI-Driven Innovation, Measurable Client Impact, and Industry-Leading Commercialization ExcellenceBERKELEY HEIGHTS, N.J., March 25, 2026 /PRNewswire/ -- Axtria Inc., a…
Product sales and commercial rights revenues in 2025 increased 90% year-over-year to US$82.1 million (RMB574.1 million)Sales of Olverembatinib increased 81% year-over-year…
NEW DELHI, March 19, 2026 /PRNewswire/ -- Roche Pharma India signed a Memorandum of Understanding (MoU) with National Institute of Pharmaceutical…
March 09, 2026 12:01 ET | Source: Zealand Pharma Press release – No. 5 / 2026 Zealand Pharma to participate…